Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers

Published:2017-12-08 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Arezumand Roghaye,Alibakhshi Abbas,Ranjbari Javad,Ramazani Ali,Muyldermans Serge

Funder

Agentschap voor Innovatie door Wetenschap en Technologie

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference109 articles.

1. Angiogenesis in cancer;Prager;Hämostaseologie,2012

2. Building better monoclonal antibody-based therapeutics;Weiner;Nat Rev Cancer,2015

3. Anti-angiogenesis therapy in cancer: current challenges and future perspectives;Shojaei;Cancer Lett,2012

4. The therapeutic monoclonal antibody market;Ecker;MAbs,2015

5. The future of monoclonal antibody technology;Zider;MAbs,2010

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RadioLabeling of the Mutant form of Anti-PlGF Nanobody by 99mTc-Tricarbonyl;Iranian Journal of Pharmaceutical Research;2024-06-02

2. Design and Production of a Novel Anti-PD-1 Nanobody by CDR Grafting and Site-Directed Mutagenesis Approach;Molecular Biotechnology;2024-05-12

3. Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer;Frontiers in Oncology;2024-04-30

4. Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its In vitro Antitumor Activity;Current Pharmaceutical Design;2024-03

5. A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab’s epitope with versatile biochemical, biological, and medical applications;Immunologic Research;2023-08-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3